Cooper C. Collins - 22 Aug 2024 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role: Director
Signature: /s/ Cooper C. Collins
Issuer symbol: TXMD
Transactions as of: 22 Aug 2024
Net transactions value: +$7,099
Form type: 4
Filing time: 26 Aug 2024, 17:40:29 UTC
Previous filing: 23 Aug 2024
Next filing: 20 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXMD	Common Stock	Purchase	$7,099	+4,094	+8.5%	$1.73	52,016	22 Aug 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $1.69 through $1.75, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices of $1.69 through $1.75, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth.